Print ISSN:-2394-2789

Online ISSN:-2394-2797

CODEN : IJPCN9




Downlaod Files

   


Article Access statistics

Viewed: 1545

PDF Downloaded: 603


Development and validation of stability indicating assay method for the estimation of lafutidine and domperidone in capsule dosage form


Full Text PDF


Original Article

Author Details : CK Gadewar, SJ Wadher, SS Pekamwar, SG Gattani

Volume : 3, Issue : 4, Year : 2016

Article Page : 219-228


Suggest article by email

Get Permission

Abstract

A simple, sensitive, precise and specific high performance liquid chromatography method was developed and validated for the determination of Lafutidine and Domperidone in Lafutidine and Domperidone sustained release capsule. The separation was carried out by using a mobile phase consisting Acetonitrile: pH 6.5 phosphate buffer in ratio of 30:70. The column used was Xterra 250mm X 4.6mm, 5µ with flow rate 1 ml/min using UV detection at 276 nm. The retention time of Lafutidine and Domperidone were found to be 7.0 and 15.5 min respectively.  Degradation study of Lafutidine and Domperidone in its capsule form was conducted under condition of hydrolysis, oxidation, thermal and photolysis, the results of analysis were validated statistically and by recovery studies (mean recovery = 99.94). The result of study showed that the proposed method is simple, rapid, precise and accurate, which is useful for the routine determination of Lafutidine and Domperidone in pharmaceutical dosage form.

Keywords: Lafutidine, Domperidone, Method development, Validation, Forced degradation



How to cite : Gadewar C, Wadher S, Pekamwar S, Gattani S, Development and validation of stability indicating assay method for the estimation of lafutidine and domperidone in capsule dosage form. Int J Pharm Chem Anal 2016;3(4):219-228


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.